The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
570 jobs Number of planned job losses
Announcement Date
29 August 2008
Employment effect (start)
Foreseen end date
Description
On 29 August 2008, the German subsidiary of UCB, a large Belgian manufacturer of pharmaceutical products, announced the reduction of its staff in Monheim by 570 persons. Around 200 jobs are to be cut in research and development, 230 in sales and 140 in internal services. The restructuring programme is being launched to overcome the adverse impact of price competition resulting from the imitation of UCB's drugs. Currently, 1,650 persons are employed by UCB at its German site in Monheim, North Rhine-Westphalia.
Sources
29 August 2008: Financial Times Deutschland
Citation
Eurofound (2008), UCB, Internal restructuring in Germany, factsheet number 67014, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/67014.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
